SCHEMBL4694873

SCHEMBL4694873

COc1ccc(Br)c(C(C(=O)O)N(CC(=O)OC(C)(C)C)C(=O)C(F)(F)F)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1D1 P20393 1/20 0.34
KEAP1 Q14145 1/20 0.33
NFE2L2 Q16236 1/20 0.33
MTNR1A P48039 1/20 0.33
MTNR1B P49286 1/20 0.33
HPGD P15428 1/20 0.32
SIGMAR1 Q99720 2/20 0.32
AKR1C3 P42330 3/20 0.31
AKR1C2 P52895 3/20 0.31
AKR1C1 Q04828 1/20 0.31
PTGS1 P23219 1/20 0.31
PSEN1 P49768 1/20 0.31
PSEN2 P49810 1/20 0.31
APH1B Q8WW43 1/20 0.31
NCSTN Q92542 1/20 0.31
APH1A Q96BI3 1/20 0.31
PSENEN Q9NZ42 1/20 0.31
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4145065 0.89 NR1D1 (0.33) NR1D1KEAP1NFE2L2MTNR1AMTNR1B
SCHEMBL4693024 0.79
SCHEMBL5261114 0.75 EDNRB (0.33) MTNR1AMTNR1B
SCHEMBL4694865 0.72 HPGD (0.38) NR1D1MTNR1AMTNR1BHPGDAKR1C3
SCHEMBL4149087 0.68 PTPN2 (0.30)
SCHEMBL5186385 0.68 EDNRB (0.32)
SCHEMBL9037513 0.68 PTGS2 (0.55) HPGDAKR1C3AKR1C2PTGS1CYP1A2
SCHEMBL4694876 0.67 MEN1 (0.36) SIGMAR1AKR1C3AKR1C2CYP1A2
SCHEMBL4138810 0.65 MAPT (0.37) MTNR1AMTNR1BHPGD
SCHEMBL4693831 0.65 AKR1C3 (0.44) HPGDAKR1C3AKR1C2AKR1C1PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1569935-B1 HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREOF AND USE OF SAME AS MEDICAMENTS, SUCH AS ANTI-BACTERIAL MEDICAMENTS AND BETA-LACTAMASE INHIBITORS NOVEXEL (FR) 2008-08-20 EP disclosed
EP-1798231-A2 Intermediate products for the preparation of antibacterial compounds NOVEXEL (FR) 2007-06-20 EP disclosed
EP-1399444-B1 NOVEL HETEROCYCLIC COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF AS MEDICINES, IN PARTICULAR AS ANTI-BACTERIAL AGENTS NOVEXEL (FR) 2007-04-11 EP disclosed